Showing 21,801 - 21,820 results of 34,608 for search '(( 5 ((point decrease) OR (nn decrease)) ) OR ( 50 ((we decrease) OR (a decrease)) ))', query time: 1.03s Refine Results
  1. 21801
  2. 21802
  3. 21803

    Excitation-Contraction Coupling in Zebrafish Ventricular Myocardium Is Regulated by Trans-Sarcolemmal Ca<sup>2+</sup> Influx and Sarcoplasmic Reticulum Ca<sup>2+</sup> Release by Moritz Haustein (734263)

    Published 2015
    “…Surprisingly though, inhibition of the sarcoplasmic Ca<sup>2+</sup>-release decreased force development to 54±3% in ventricular (n=13, p<0.05) and to 52±8% in atrial myocardium (n=5, p<0.05) suggesting a substantial role of SR Ca<sup>2+</sup>-release in force generation. …”
  4. 21804

    Simplified metabolic networks of ASPC-1 cells as determined by proton NMR spectroscopy. by Andrej Udelnow (350968)

    Published 2013
    “…The most obvious changes is that the PC/Cho ratio is significantly lower in the OMP group compared to the control group. Upon 5-FU, the Cho/Acetate ratio decrease is the only significant change. …”
  5. 21805

    An amine oxidase gene from mud crab, <i>Scylla paramamosain</i>, regulates the neurotransmitters serotonin and dopamine <i>in vitro</i> by Junguo Liu (126628)

    Published 2018
    “…These results indicated that quercetin could inhibit the transcription of <i>SpAMO</i>, and the high dose (50 mg/kg/d) had a relatively significant inhibitory effect. …”
  6. 21806
  7. 21807
  8. 21808
  9. 21809

    Table1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Suppress... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  10. 21810

    DataSheet3_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  11. 21811

    DataSheet4_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  12. 21812

    DataSheet1_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  13. 21813

    DataSheet6_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  14. 21814

    DataSheet5_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  15. 21815

    DataSheet2_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  16. 21816

    DataSheet7_Chinese Patent Medicine Liuweiwuling Tablet had Potent Inhibitory Effects on Both Wild-Type and Entecavir-Resistant Hepatitis B Virus (HBV) in vitro and Effectively Supp... by Fei-lin Ge (11611192)

    Published 2021
    “…The inhibition rates of LWWL (0.8 mg/ml) on HBV DNA, HBsAg, and pgRNA were 57.06, 38.55, and 62.49% in HepG2.2.15 cells, and 51.57, 17.57, and 53.88% in HepG2. A64 cells, respectively. LWWL (2 g kg<sup>−1</sup> d<sup>−1</sup> for 4 weeks)-treated mice had 1.16 log<sub>10</sub> IU/mL decrease of serum HBV DNA, and more than 50% decrease of serum HBsAg/HBeAg and hepatic HBsAg/HBcAg. …”
  17. 21817

    Compound activity of PMP-311 and PMP-072 on α7 nAChR. by Marjolein A. van Maanen (685989)

    Published 2015
    “…<b>E</b>, When PMP-072 was co-applied with 60 μM ACh to Xenopus oocytes voltage-clamped at 60 mV there was a concentration dependent decrease in the responses compared to ACh applied alone suggesting that with this experimental approach PMP-072 an antagonist of ACh-evoked α7 nAChR channel activation. …”
  18. 21818

    The time trace of the M-like intermediate was measured at 400 nm (upper panel) by Richard A Krebs (596)

    Published 2011
    “…</p><p>BMC Physiology 2002;2():5-5.</p><p>Published online 9 Apr 2002</p><p>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC103662/</p><p>Copyright © 2002 Krebs et al; licensee BioMed Central Ltd. …”
  19. 21819

    The result of a density multiplying simulation. by Atsushi Honma (246212)

    Published 2008
    “…<p>The densities of the Mimic and the Model vary between 0 and 0.5 while their ratio remains constant (1∶1). Each point and error bar represent the mean and standard deviation of the replications. …”
  20. 21820